The FDA approval of Kymriah marks the first CAR-T cell-based gene therapy available in the US

When looking to do good, many companies choose to focus on children’s health, particularly in developing countries.

A small-molecule drug has shown its ability to diminish HIV reservoirs.

The FDA aims to reduce drug prices with a more competitive market - and generics are key.

Pfizer researchers share the story behind the first JAK inhibitor for rheumatoid arthritis

Free cancer drugs, mispackaged contraceptive pills, and antibiotic action… What's new for pharma in business?

Real-time monitoring and analysis of biologics during manufacturing is within reach

A new database hopes to be the perfect tool for finding new novel drug combinations

Drugs could become more potent when using micromotor-laden sperm to deliver them

Tightly controlled trials are poor predictors of real-world outcomes